{"nct_id":"NCT00932893","title":"An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2012-03","primary_completion_date_type":"ACTUAL","completion_date":"2016-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}